MetLife SEC Filings

MetLife, Inc. has reorganized its business structure to highlight growth in asset management. In the fourth quarter of 2025, the company made MetLife Investment Management (MIM), its institutional asset management unit, a separate reportable segment, while MetLife Holdings is no longer a reportable segment and is now mainly included in Corporate & Other. Certain products formerly in MetLife Holdings have been reclassified into Group Benefits and Retirement and Income Solutions (RIS).

Following these changes, MetLife is now organized into six segments: Group Benefits, RIS, Asia, Latin America, Europe, the Middle East and Africa, and MIM, with additional results in Corporate & Other. Effective January 1, 2025, MetLife also amended agreements between MIM and MetLife entities so that MIM manages general account assets at current market fee rates, compared with 2024 terms. The company states that these updates did not change prior period consolidated net income or consolidated adjusted earnings and has provided a Historical Results Financial Supplement to help investors compare past periods under the new structure.

The Vanguard Group reported its ownership of MetLife Inc. common stock as of 12/31/2025. Vanguard beneficially owned 72,555,322 MetLife shares, representing 11.01 % of the outstanding common stock. Vanguard reported no sole voting power, shared voting power over 3,509,125 shares, sole dispositive power over 66,835,767 shares, and shared dispositive power over 5,719,555 shares.

The filing states that Vanguard is an investment adviser and that the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of MetLife. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends and sale proceeds from these securities, and no single other person has an interest in more than five percent of the class.

MetLife, Inc. filed a report showing a director acquired additional common stock as part of standard board compensation. On 01/02/2026, the director received 639 shares of MetLife common stock at a price of $80.32 per share, recorded as an acquisition. After this transaction, the director beneficially owned 8,064 shares held directly.

The company explains that non-management directors receive a portion of their retainer fees in MetLife common stock. In this case, the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, so the award reflects compensation rather than an open-market purchase.

MetLife, Inc. director reported receiving common stock as part of non-management director compensation on 01/02/2026. The filing shows an acquisition of 639 shares of MetLife common stock at $80.32 per share, bringing the director's directly held position to 45,415 shares. An additional 10 shares are reported as indirectly owned through the MetLife Policyholder Trust.

The company’s arrangements pay a portion of non-management director retainer fees in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

MetLife, Inc. disclosed that one of its directors received 639 shares of MetLife common stock on 01/02/2026 as part of non‑management director compensation, at a reported price of $0 per share. After this grant, the director beneficially owned 18,080 shares of MetLife common stock in direct ownership. The company notes that its compensation arrangements pay a portion of non‑management director retainer fees in MetLife common stock rather than cash.

MetLife, Inc. reported a routine director equity compensation transaction. A non-management director acquired 639 shares of MetLife common stock on 01/02/2026 at $80.32 per share as part of the standard director retainer paid in stock. Following this transaction, the director beneficially owned 2,108 shares directly.

The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the stock represents compensation that is being deferred rather than an open-market purchase.

MetLife, Inc. disclosed that one of its non-management directors received additional common stock as part of regular board compensation. On 01/02/2026, the director acquired 639 shares of MetLife common stock at a stated price of $0 per share, reflecting stock paid in lieu of a portion of cash retainer fees. Following this transaction, the director beneficially owns 33,990 shares of MetLife common stock in direct ownership. The filing notes that MetLife’s non-management director compensation arrangements provide that a portion of director retainer fees is paid in MetLife common stock.

MetLife, Inc. director Carlos M. Gutierrez reported receiving additional common stock as part of non-management director compensation. On 01/02/2026, he acquired 639 shares of MetLife common stock at a price of $0 per share, reflecting payment of a portion of his retainer fees in stock rather than cash. Following this transaction, he beneficially owns 25,024 shares directly and 18,807 shares indirectly through the Carlos M. Gutierrez Trust.

METLIFE, INC. reported that one of its directors acquired common stock as part of standard non-management director compensation. On 01/02/2026, the director received 639 shares of MetLife common stock at a price of $80.32 per share, recorded as an acquisition. After this transaction, the director beneficially owned 9,721 shares of MetLife common stock in direct ownership.

A portion of non-management director retainer fees is paid in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. The filing is made by one reporting person in the capacity of a director.